Defining Japan’s Pharma Market: Insider Analysis From International Alliances Ltd.’s Reed Maurer
This article was originally published in PharmAsia News
Long-time Japan pharma expert Reed Maurer outlines some of the common misconceptions companies have about entering the Japanese reimbursement system and why Japan should be considered a “re-emerging market.”
You may also be interested in...
How Drugs Are Distributed In Japan: Insider Analysis From International Alliances Ltd.’s Reed Maurer
A closer look at components of Japan’s distribution system reveals a vastly improved network than previous years.